Lyell Immunopharma, Inc. (LYEL)

Lyell Immunopharma Revenue

Lyell Immunopharma had revenue of $7.00K in the quarter ending March 31, 2025, with 133.33% growth. This brings the company's revenue in the last twelve months to $65.00K, down -4.41% year-over-year. In the year 2024, Lyell Immunopharma had annual revenue of $61.00K, down -53.08%.

• Revenue (ttm): $65.00K
• Revenue Growth: -4.41%
• P/S Ratio: 2,036.68
• Revenue / Employee: $217
• Employees: 300
• Market Cap: 132.38M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	61.00K	-69.00K	-53.08%
Dec 31, 2023	130.00K	-84.55M	-99.85%
Dec 31, 2022	84.68M	74.03M	695.15%
Dec 31, 2021	10.65M	2.89M	37.31%
Dec 31, 2020	7.76M	7.10M	1,080.52%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.